Is BHC or BLRX more undervalued in 2026?

CirclFi compares Bausch Health Companies Inc. (BHC) and BioLineRx Ltd. (BLRX) using 13 institutional-grade valuation models. BHC has a Quality of Company score of 5.8/10 while BLRX scores 1.5/10.

Which is a better buy — BHC or BLRX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BHC and BLRX valuations compare?

BHC at $5.36 and BLRX at $3.78 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BHC vs BLRX Valuation Comparison 2026 — Intrinsic Value Analysis

BHC

Pharmaceutical Preparations

Bausch Health Companies Inc.

Quality

5.8

out of 10

Value Trap

SAFE

Price

$5.36

Last close

Models

8/13

Active

BLRX

Pharmaceutical Preparations

BioLineRx Ltd.

Quality

1.5

out of 10

Value Trap

SAFE

Price

$3.78

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	BHC Fair Value	BHC Upside	BLRX Fair Value	BLRX Upside
Bayesian DCF	Intrinsic	$10.37	+82.9%	$0.71	-81.1%
Earnings Power Value	Intrinsic	$1.11	-80.3%	$1.00	-65.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BHC vs BLRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BHC vs BLRX — Which Stock Is More Undervalued?

BHC scores higher with a 5.8/10 quality rating vs BLRX's 1.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bausch Health Companies Inc. (BHC) and BioLineRx Ltd. (BLRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BHC currently trades at $5.36 with a QOC of 5.8/10, while BLRX trades at $3.78 with a QOC of 1.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).